Lanlan Jing

865 total citations
22 papers, 623 citations indexed

About

Lanlan Jing is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Lanlan Jing has authored 22 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 13 papers in Virology and 10 papers in Organic Chemistry. Recurrent topics in Lanlan Jing's work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (13 papers) and Click Chemistry and Applications (6 papers). Lanlan Jing is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (13 papers) and Click Chemistry and Applications (6 papers). Lanlan Jing collaborates with scholars based in China, Belgium and United States. Lanlan Jing's co-authors include Xinyong Liu, Dongwei Kang, Peng Zhan, Gaochan Wu, Xiangyi Jiang, Xia Hao, Erik De Clercq, Christophe Pannecouque, Zhongxia Zhou and Da Feng and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Lanlan Jing

20 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lanlan Jing China	13	325	258	221	206	103	22	623
Xiangyi Jiang China	14	322 1.0×	345 1.3×	275 1.2×	274 1.3×	167 1.6×	43	729
Chih Y. Ho United States	9	307 0.9×	291 1.1×	230 1.0×	221 1.1×	103 1.0×	11	626
Emanuela Nizi Italy	13	302 0.9×	159 0.6×	238 1.1×	82 0.4×	96 0.9×	19	609
Cristina Gardelli Italy	14	287 0.9×	239 0.9×	202 0.9×	125 0.6×	84 0.8×	26	584
Sanjeev Kumar V. Vernekar United States	13	271 0.8×	246 1.0×	235 1.1×	181 0.9×	53 0.5×	16	577
Lucien M. H. Koymans Belgium	6	187 0.6×	400 1.6×	236 1.1×	331 1.6×	142 1.4×	7	658
Joseph W. Strohbach United States	15	470 1.4×	328 1.3×	230 1.0×	246 1.2×	61 0.6×	19	850
Damien Marchand Belgium	8	141 0.4×	254 1.0×	329 1.5×	255 1.2×	39 0.4×	12	519
Alessia Petrocchi Italy	11	138 0.4×	258 1.0×	298 1.3×	146 0.7×	92 0.9×	18	561
Vandna Munshi United States	13	227 0.7×	357 1.4×	208 0.9×	278 1.3×	105 1.0×	14	592

Countries citing papers authored by Lanlan Jing

Since Specialization

Citations

This map shows the geographic impact of Lanlan Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Jing more than expected).

Fields of papers citing papers by Lanlan Jing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Jing. The network helps show where Lanlan Jing may publish in the future.

Co-authorship network of co-authors of Lanlan Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Jing. A scholar is included among the top collaborators of Lanlan Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Jing. Lanlan Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jing, Lanlan, Fabao Zhao, Lin Zheng, et al.. (2025). Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method. International Journal of Molecular Sciences. 26(2). 670–670.

Jing, Lanlan, Gaochan Wu, Fabao Zhao, et al.. (2024). Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization. European Journal of Medicinal Chemistry. 277. 116772–116772. 4 indexed citations

Jing, Lanlan, Tao Zhang, Ying Liu, et al.. (2024). Discovery of Novel Amino Acids (Analogues)-Substituted Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis, and Biological Evaluation. International Journal of Molecular Sciences. 25(16). 9028–9028.

Zhang, Heng, Jing Li, Károly Tóth, et al.. (2023). Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration. Bioorganic & Medicinal Chemistry. 96. 117531–117531. 4 indexed citations

Jing, Lanlan, Ye Tian, Anna Więckowska, et al.. (2023). Multifunctional agents against Alzheimer’s disease based on oxidative stress: Polysubstituted pyrazine derivatives synthesized by multicomponent reactions. Bioorganic & Medicinal Chemistry. 96. 117535–117535. 4 indexed citations

Jiang, Xiangyi, Jing Li, F. Javier Luque, et al.. (2023). Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors via click-chemistry-based rapid screening. RSC Medicinal Chemistry. 14(10). 2068–2078. 10 indexed citations

Jing, Lanlan, Florian Nachon, Ana Martı́nez, et al.. (2023). Rapid discovery and crystallography study of highly potent and selective butylcholinesterase inhibitors based on oxime-containing libraries and conformational restriction strategies. Bioorganic Chemistry. 134. 106465–106465. 7 indexed citations

Gao, Shenghua, Hongtao Xu, Steven De Jonghe, et al.. (2022). Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors. Molecules. 28(1). 160–160. 6 indexed citations

Kang, Dongwei, Yanying Sun, Da Feng, et al.. (2022). Development of Novel Dihydrofuro[3,4-d]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C. Journal of Medicinal Chemistry. 65(3). 2458–2470. 14 indexed citations

10.

Sun, Yanying, Da Feng, Lanlan Jing, et al.. (2022). Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs. Journal of Medicinal Chemistry. 65(23). 15608–15626. 9 indexed citations

11.

Kang, Dongwei, Francesc X. Ruiz, Yanying Sun, et al.. (2021). 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies. Journal of Medicinal Chemistry. 64(7). 4239–4256. 40 indexed citations

12.

Feng, Da, Lanlan Jing, Chin‐Ho Chen, et al.. (2020). Design, synthesis, and evaluation of “dual-site”-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase. European Journal of Medicinal Chemistry. 211. 113063–113063. 16 indexed citations

13.

Kang, Dongwei, Da Feng, Lanlan Jing, et al.. (2020). In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP. European Journal of Medicinal Chemistry. 193. 112237–112237. 27 indexed citations

14.

Kang, Dongwei, Tong Zhao, Zhao Wang, et al.. (2019). Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors. Communications Chemistry. 2(1). 29 indexed citations

15.

Jiang, Xiangyi, Gaochan Wu, Waleed A. Zalloum, et al.. (2019). Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors. RSC Advances. 9(50). 28961–28986. 53 indexed citations

16.

Jiang, Xiangyi, Xia Hao, Lanlan Jing, et al.. (2019). Recent applications of click chemistry in drug discovery. Expert Opinion on Drug Discovery. 14(8). 779–789. 201 indexed citations

17.

Kang, Dongwei, Zhao Wang, Heng Zhang, et al.. (2018). Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery. ACS Medicinal Chemistry Letters. 9(4). 370–375. 29 indexed citations

18.

Huo, Zhipeng, Heng Zhang, Dongwei Kang, et al.. (2018). Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the “NNRTI Adjacent” Binding Site. ACS Medicinal Chemistry Letters. 9(4). 334–338. 33 indexed citations

19.

Wu, Gaochan, Waleed A. Zalloum, Megan E. Meuser, et al.. (2018). Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library. European Journal of Medicinal Chemistry. 158. 478–492. 55 indexed citations

20.

Wang, Zhao, Dongwei Kang, Meng Chen, et al.. (2018). Design, synthesis, and antiviral evaluation of novel hydrazone‐substituted thiophene[3,2‐d]pyrimidine derivatives as potent human immunodeficiency virus‐1 inhibitors. Chemical Biology & Drug Design. 92(6). 2009–2021. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact